Translational Neuroscience Drug Discovery Course

This spring the TNC will be offering a short course on the basics of preclinical drug discovery for the neuroscience community. It is intended to give translational neuroscientists insight into the drug discovery process and an overview of the local pharmaceutical industry landscape. Lectures from local industry experts will be offered to cover different aspects of the drug discovery process. Lectures will be in CLS12 on each Wednesday from April 4 to May 9 at 4:00-5:00pm. Don’t miss this opportunity! Online registration now available. For questions, please contact tnc@childrens.harvard.edu.

Drug Discovery for Neuroscientists

Wednesdays 4-5pm, CLS 12

April 4^th – May 9^th, 2018

(Please note the exception: Early Phase Clinical Trials with Keith Gottesdiener will be held on Tuesday, May 1, 2018)

Agenda:

4/4/18 Introduction to Drug Discovery

Meera Modi, BCH

4/11/18 Biology: Building a Preclinical Rationale

Robin Kleiman, Biogen

4/18/18 Animal Models in Drug Discovery

Michelle Sidor, Novartis Institute for BioMedical Research

4/25/18 A Case Study in PK/PD

Stephen Wood, Amgen

5/1/18 Early Phase Clinical Trials

Keith Gottesdiener, Rhythm Pharmaceuticals

5/9/18 The Interface Between Industry and Academia

Nick Brandon, AstraZeneca